Medical and Pharmaceutical Alarming CT radiation study highlights need for alternative diagnostic tools University of California researchers have determined that these machines can cause 1 out of every 20 new cancer cases Rowan Dunne2 days ago
Medical and Pharmaceutical How could a simple blood test could eliminate tumour biopsies? The company has received support from the Centre of Expertise in Advanced Materials and Sustainability and Innovate UK Joseph Morton2 days ago
Medical and Pharmaceutical Lung cancer breath test demonstrates remarkable efficacy in Dutch study It correctly identified positive cases with 80 to 92% accuracy Rowan Dunne3 days ago
Medical and Pharmaceutical Smokers skipping lung cancer screenings: study Lung cancer remains the leading cause of cancer death in the United States Joseph MortonApril 10, 2025
Medical and Pharmaceutical Median Technologies clears hurdle on the way to regulatory acceptance in EU and US The company has met a key requirement for regulatory submissions in the US and Europe Joseph MortonApril 3, 2025
Medical and Pharmaceutical South Korean research institution develops lung cancer breath test with 95% accuracy It uses a machine with 70 sensors to detect volatile organic compounds associated with the disease Rowan DunneMarch 25, 2025
Health and Safety Five startups taking aim at cancer diagnosis and treatment Statistics Canada reports that lung cancer was the leading cause for both men and women Joseph MortonMarch 21, 2025
Medical and Pharmaceutical Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump The deal could provide shareholders with an extra $0.70 per share if company's drug gains regulatory approval in Europe Joseph MortonMarch 10, 2025
Medical and Pharmaceutical Poor people die of cancer more than rich: UK research Nearly half of the 28,400 additional cancer deaths linked to deprivation are due to lung cancer Joseph MortonFebruary 24, 2025
Medical and Pharmaceutical New Korean cancer tech finds mutations with only a few drops of blood In a clinical trial with blood from 83 patients, the test identified 100 per cent of EGFR gene mutations Joseph MortonFebruary 18, 2025